DIA412.26-0.78 -0.19%
SPX5,650.38-36.29 -0.64%
IXIC17,844.24-133.49 -0.74%

EuroEyes International Eye Clinic's (HKG:1846) Shareholders Have More To Worry About Than Only Soft Earnings

Simply Wall St·05/01/2025 22:29:36
Listen to the news

A lackluster earnings announcement from EuroEyes International Eye Clinic Limited (HKG:1846) last week didn't sink the stock price. Our analysis suggests that along with soft profit numbers, investors should be aware of some other underlying weaknesses in the numbers.

Our free stock report includes 2 warning signs investors should be aware of before investing in EuroEyes International Eye Clinic. Read for free now.
earnings-and-revenue-history
SEHK:1846 Earnings and Revenue History May 1st 2025

How Do Unusual Items Influence Profit?

To properly understand EuroEyes International Eye Clinic's profit results, we need to consider the HK$22m gain attributed to unusual items. While we like to see profit increases, we tend to be a little more cautious when unusual items have made a big contribution. We ran the numbers on most publicly listed companies worldwide, and it's very common for unusual items to be once-off in nature. Which is hardly surprising, given the name. Assuming those unusual items don't show up again in the current year, we'd thus expect profit to be weaker next year (in the absence of business growth, that is).

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

Our Take On EuroEyes International Eye Clinic's Profit Performance

Arguably, EuroEyes International Eye Clinic's statutory earnings have been distorted by unusual items boosting profit. Therefore, it seems possible to us that EuroEyes International Eye Clinic's true underlying earnings power is actually less than its statutory profit. In further bad news, its earnings per share decreased in the last year. The goal of this article has been to assess how well we can rely on the statutory earnings to reflect the company's potential, but there is plenty more to consider. If you'd like to know more about EuroEyes International Eye Clinic as a business, it's important to be aware of any risks it's facing. Case in point: We've spotted 2 warning signs for EuroEyes International Eye Clinic you should be aware of.

Today we've zoomed in on a single data point to better understand the nature of EuroEyes International Eye Clinic's profit. But there are plenty of other ways to inform your opinion of a company. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks with significant insider holdings to be useful.

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit:  https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.